T Onega1,2,3, W Zhu4, J E Weiss1, M Goodrich5, A N A Tosteson2,3, W DeMartini6, B A Virnig7, L M Henderson8, D S M Buist4, K J Wernli4, K Kerlikowske9, R A Hubbard10. 1. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, HB 7927 Rubin 8 - DHMC, Lebanon, 03756, USA. 2. Norris Cotton Cancer Center, Lebanon, NH, USA. 3. The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 4. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. 5. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, HB 7927 Rubin 8 - DHMC, Lebanon, 03756, USA. Tracy.L.Onega@dartmouth.edu. 6. Department of Radiology, Stanford University, Palo Alto, CA, USA. 7. Division of Health Policy and Management, University of Minnesota, Minneapolis, MN, USA. 8. Department of Radiology, The University of North Carolina, Chapel Hill, NC, USA. 9. Department of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, USA. 10. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
PURPOSE: The survival benefit from detecting additional breast cancers by preoperative magnetic resonance imaging (MRI) continues to be controversial. METHODS: We followed a cohort of 4454 women diagnosed with non-metastatic breast cancer (stage I-III) from 2/2005-6/2010 in five registries of the breast cancer surveillance consortium (BCSC). BCSC clinical and registry data were linked to Medicare claims and enrollment data. We estimated the cumulative probability of breast cancer-specific and all-cause mortality. We tested the association of preoperative MRI with all-cause mortality using a Cox proportional hazards model. RESULTS: 917 (20.6%) women underwent preoperative MRI. No significant difference in the cumulative probability of breast cancer-specific mortality was found. We observed no significant difference in the hazard of all-cause mortality during the follow-up period after adjusting for sociodemographic and clinical factors among women with MRI (HR 0.90; 95% CI 0.72-1.12) compared to those without MRI. CONCLUSION: Our findings of no breast cancer-specific or all-cause mortality benefit supplement prior results that indicate a lack of improvement in surgical outcomes associated with use of preoperative MRI. In combination with other reports, the results of this analysis highlight the importance of exploring the benefit of preoperative MRI in patient-reported outcomes such as women's decision quality and confidence levels with decisions involving treatment choices.
PURPOSE: The survival benefit from detecting additional breast cancers by preoperative magnetic resonance imaging (MRI) continues to be controversial. METHODS: We followed a cohort of 4454 women diagnosed with non-metastatic breast cancer (stage I-III) from 2/2005-6/2010 in five registries of the breast cancer surveillance consortium (BCSC). BCSC clinical and registry data were linked to Medicare claims and enrollment data. We estimated the cumulative probability of breast cancer-specific and all-cause mortality. We tested the association of preoperative MRI with all-cause mortality using a Cox proportional hazards model. RESULTS: 917 (20.6%) women underwent preoperative MRI. No significant difference in the cumulative probability of breast cancer-specific mortality was found. We observed no significant difference in the hazard of all-cause mortality during the follow-up period after adjusting for sociodemographic and clinical factors among women with MRI (HR 0.90; 95% CI 0.72-1.12) compared to those without MRI. CONCLUSION: Our findings of no breast cancer-specific or all-cause mortality benefit supplement prior results that indicate a lack of improvement in surgical outcomes associated with use of preoperative MRI. In combination with other reports, the results of this analysis highlight the importance of exploring the benefit of preoperative MRI in patient-reported outcomes such as women's decision quality and confidence levels with decisions involving treatment choices.
Entities:
Keywords:
Breast cancer; Breast cancer mortality; Breast cancer treatment; Preoperative breast MRI
Authors: Louise M Henderson; Julie Weiss; Rebecca A Hubbard; Cristina O'Donoghue; Wendy B DeMartini; Diana S M Buist; Karla Kerlikowske; Martha Goodrich; Beth Virnig; Anna N A Tosteson; Constance D Lehman; Tracy Onega Journal: Breast J Date: 2015-10-28 Impact factor: 2.431
Authors: J A van Dongen; A C Voogd; I S Fentiman; C Legrand; R J Sylvester; D Tong; E van der Schueren; P A Helle; K van Zijl; H Bartelink Journal: J Natl Cancer Inst Date: 2000-07-19 Impact factor: 13.506
Authors: Nehmat Houssami; Robin Turner; Petra Macaskill; Lindsay W Turnbull; David R McCready; Todd M Tuttle; Neha Vapiwala; Lawrence J Solin Journal: J Clin Oncol Date: 2014-01-06 Impact factor: 44.544
Authors: N H G M Peters; S van Esser; M A A J van den Bosch; R K Storm; P W Plaisier; T van Dalen; S C E Diepstraten; T Weits; P J Westenend; G Stapper; M A Fernandez-Gallardo; I H M Borel Rinkes; R van Hillegersberg; W P Th M Mali; P H M Peeters Journal: Eur J Cancer Date: 2010-12-30 Impact factor: 9.162
Authors: Matthew M Poggi; David N Danforth; Linda C Sciuto; Sharon L Smith; Seth M Steinberg; David J Liewehr; Cynthia Menard; Marc E Lippman; Allen S Lichter; Rosemary M Altemus Journal: Cancer Date: 2003-08-15 Impact factor: 6.860
Authors: Richard J Bleicher; Robin M Ciocca; Brian L Egleston; Linda Sesa; Kathryn Evers; Elin R Sigurdson; Monica Morrow Journal: J Am Coll Surg Date: 2009-06-18 Impact factor: 6.113
Authors: Karen Sepucha; Steven J Atlas; Yuchiao Chang; Janet Dorrwachter; Andrew Freiberg; Mahima Mangla; Harry E Rubash; Leigh H Simmons; Thomas Cha Journal: J Bone Joint Surg Am Date: 2017-08-02 Impact factor: 5.284
Authors: Tracy Onega; Anna N A Tosteson; Julie Weiss; Jennifer Alford-Teaster; Rebecca A Hubbard; Louise M Henderson; Karla Kerlikowske; Martha E Goodrich; Cristina O'Donoghue; Karen J Wernli; Wendy B DeMartini; Beth A Virnig Journal: BMC Health Serv Res Date: 2016-02-27 Impact factor: 2.655
Authors: Gabriel De la Cruz Ku; Manish Karamchandani; Diego Chambergo-Michilot; Alexis R Narvaez-Rojas; Michael Jonczyk; Fortunato S Príncipe-Meneses; David Posawatz; Salvatore Nardello; Abhishek Chatterjee Journal: Ann Surg Oncol Date: 2022-07-25 Impact factor: 4.339
Authors: Karen J Wernli; Rebecca E Smith; Louise M Henderson; Wenyan Zhao; Danielle D Durham; Karen Schifferdecker; Celia Kaplan; Diana S M Buist; Karla Kerlikowske; Diana L Miglioretti; Tracy Onega; Nila H Alsheik; Brian L Sprague; Gloria Jackson-Nefertiti; Jill Budesky; Dianne Johnson; Anna N A Tosteson Journal: Breast Cancer Res Treat Date: 2022-06-20 Impact factor: 4.624